Perbedaan Organon Pharma Indonesia Tbk. dan Wira Global Solusi Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wira Global Solusi Tbk. diperdagangkan di Rp136 (kapitalisasi pasar 293,99 M, volume 24 jam 26,27 jt). Perbedaan utamanya: Wira Global Solusi Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WGSH | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 293,99 M |
Volume | — | 26,27 jt |
Lot | — | 262,7 rb |
Perputaran | — | 3,62 M |
Harga Rata-rata | — | 137,74 |
Nilai Transaksi | — | 3,62 M |
Harga Ekuilibrium Indikatif | — | 136 |
Volume Ekuilibrium Indikatif | — | 765 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Wira Global Solusi Tbk (the Company) was established under name PT Gcloud Teknologi Informasi based on Deed No. 5 dated September 7, 2015 of Bhuana Nurinsani, S.H., notary in Bandung. Ikin Wirawan is the ultimate beneficial owner and controlling shareholder of the Company.
Selengkapnya di halaman WGSH →